tiprankstipranks
Inhibrx Biosciences, Inc. (INBX)
NASDAQ:INBX
US Market

Compare Inhibrx Biosciences Inc (INBX) vs. Competitors

58 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Inhibrx Biosciences Inc
$85.32
$980.57M
513.36%
1 Buy
0 Hold
0 Sell
Moderate Buy
Prothena
$10.65
$569.55M
-2.11
3.12%
2 Buy
1 Hold
1 Sell
Hold
CytomX Therapeutics
$4.25
$916.59M
-33.83
748.00%
9 Buy
0 Hold
0 Sell
Strong Buy
Humacyte
$0.65
$134.77M
-3.72
-60.33%
5 Buy
1 Hold
0 Sell
Strong Buy
Monte Rosa Therapeutics
$17.12
$1.44B
-33.72
344.58%
7 Buy
0 Hold
0 Sell
Strong Buy
Candel Therapeutics
$4.95
$351.59M
-7.84
-5.79%
4 Buy
1 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
INBX
Inhibrx Biosciences Inc
75.75
64.43
569.17%
PRTA
Prothena
10.58
0.89
9.18%
CTMX
CytomX Therapeutics
4.24
3.75
758.30%
HUMA
Humacyte
0.61
-0.96
-61.34%
GLUE
Monte Rosa Therapeutics
18.05
13.90
334.94%
CADL
Candel Therapeutics
4.80
0.03
0.63%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts